{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:07:14Z","timestamp":1786993634853,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":471,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007921","name":"University of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T32HL98036"],"award-info":[{"award-number":["T32HL98036"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvsvenous.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery: Venous and Lymphatic Disorders"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jvsv.2023.06.003","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T22:27:03Z","timestamp":1687386423000},"page":"1157-1164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Predictors of chronic thromboembolic pulmonary hypertension in patients with submassive pulmonary embolism treated with catheter-directed thrombolysis versus anticoagulation alone: A secondary analysis of the SUNSET sPE trial"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6536-070X","authenticated-orcid":false,"given":"Elizabeth A.","family":"Andraska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian","family":"Bonaroti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6947-2901","authenticated-orcid":false,"given":"Yingze","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Rivera-Lebron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabih A.","family":"Chaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efthymios D.","family":"Avgerinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvsv.2023.06.003_bib1","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(11)61904-1","article-title":"Pulmonary embolism and deep vein thrombosis","volume":"379","author":"Goldhaber","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jvsv.2023.06.003_bib2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.blre.2014.07.003","article-title":"The post-PE syndrome: a new concept for chronic complications of pulmonary embolism","volume":"28","author":"Klok","year":"2014","journal-title":"Blood Rev"},{"key":"10.1016\/j.jvsv.2023.06.003_bib3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/686011","article-title":"Current concepts in the pathogenesis of chronic thromboembolic pulmonary hypertension","volume":"6","author":"Matthews","year":"2016","journal-title":"Pulm Circ"},{"key":"10.1016\/j.jvsv.2023.06.003_bib4","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/j.jacc.2020.08.074","article-title":"Chronic thromboembolic pulmonary hypertension: JACC focus seminar","volume":"76","author":"Papamatheakis","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"Suppl 3","key":"10.1016\/j.jvsv.2023.06.003_bib5","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.1513\/AnnalsATS.201509-619AS","article-title":"From acute to chronic thromboembolic disease","volume":"13","author":"Fernandes","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jvsv.2023.06.003_bib6","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa032274","article-title":"Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism","volume":"350","author":"Pengo","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvsv.2023.06.003_bib7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1183\/09031936.00087608","article-title":"Risk factors for chronic thromboembolic pulmonary hypertension","volume":"33","author":"Bonderman","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jvsv.2023.06.003_bib8","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1538-7836.2009.03726.x","article-title":"Quality of life after pulmonary embolism: validation of the PEmb-QoL Questionnaire","volume":"8","author":"Klok","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jvsv.2023.06.003_bib9","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1016\/j.chest.2021.01.071","article-title":"Quality of life 3 and 12 Months following acute pulmonary embolism: analysis from a prospective multicenter cohort study","volume":"159","author":"Valerio","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.jvsv.2023.06.003_bib10","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.chest.2021.07.056","article-title":"Executive summary: antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report","volume":"160","author":"Stevens","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.jvsv.2023.06.003_bib11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.amjmed.2018.10.015","article-title":"Outcomes of catheter-directed therapy plus anticoagulation versus anticoagulation alone for submassive and massive pulmonary embolism","volume":"132","author":"Hennemeyer","year":"2019","journal-title":"Am J Med"},{"key":"10.1016\/j.jvsv.2023.06.003_bib12","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s11239-021-02481-9","article-title":"Safety and efficacy of catheter-directed therapy versus anticoagulation alone in a higher-risk acute pulmonary embolism population","volume":"52","author":"Putnam","year":"2021","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jvsv.2023.06.003_bib13","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jcin.2021.04.049","article-title":"Randomized trial comparing standard versus ultrasound-assisted thrombolysis for submassive pulmonary embolism: the SUNSET sPE trial","volume":"14","author":"Avgerinos","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvsv.2023.06.003_bib14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1741-7015-8-18","article-title":"CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials","volume":"8","author":"Schulz","year":"2010","journal-title":"BMC Med"},{"key":"10.1016\/j.jvsv.2023.06.003_bib15","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"61","author":"Humbert","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jvsv.2023.06.003_bib16","article-title":"ERS statement on chronic thromboembolic pulmonary hypertension","volume":"57","author":"Delcroix","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jvsv.2023.06.003_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/pul2.12091","article-title":"CXCL10 levels in diagnosis and improved hemodynamics in patients with chronic thromboembolic pulmonary hypertension undergoing balloon pulmonary angioplasty","volume":"12","author":"Hong","year":"2022","journal-title":"Pulm Circ"},{"key":"10.1016\/j.jvsv.2023.06.003_bib18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.healun.2022.10.026","article-title":"Circulating markers of inflammation and angiogenesis and clinical outcomes across subtypes of pulmonary arterial hypertension","volume":"42","author":"Hirsch","year":"2023","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jvsv.2023.06.003_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113086","article-title":"Pentraxin3 in chronic thromboembolic pulmonary hypertension: a new biomarker for screening from remitted pulmonary thromboembolism","volume":"9","author":"Naito","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jvsv.2023.06.003_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045834","article-title":"Human pentraxin 3 (PTX3) as a novel biomarker for the diagnosis of pulmonary arterial hypertension","volume":"7","author":"Tamura","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jvsv.2023.06.003_bib21","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.thromres.2013.06.016","article-title":"Quality of life after pulmonary embolism as assessed with SF-36 and PEmb-QoL","volume":"132","author":"van Es","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.jvsv.2023.06.003_bib22","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1378\/chest.113.3.619","article-title":"Validation of a new dyspnea measure: the UCSD shortness of breath questionnaire. University of California, san Diego","volume":"113","author":"Eakin","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.jvsv.2023.06.003_bib23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/j.jvsv.2023.06.003_bib24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12265-020-10006-7","article-title":"Chemokines in myocardial infarction","volume":"14","author":"Chen","year":"2021","journal-title":"J\u00a0Cardiovasc Transl Res"},{"key":"10.1016\/j.jvsv.2023.06.003_bib25","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1007\/s12265-022-10253-w","article-title":"Pentraxin 3 in circulating microvesicles: a potential biomarker for acute heart failure after cardiac surgery with cardiopulmonary bypass","volume":"15","author":"Song","year":"2022","journal-title":"J\u00a0Cardiovasc Transl Res"},{"key":"10.1016\/j.jvsv.2023.06.003_bib26","article-title":"Utility of elevated pentraxin-3 level as inflammatory marker for predicting adverse outcomes in patients with acute coronary syndrome: a meta-analysis","volume":"8","author":"Fan","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jvsv.2023.06.003_bib27","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1001\/jamacardio.2022.3591","article-title":"Catheter-directed thrombolysis vs anticoagulation in patients with acute intermediate-high-risk pulmonary embolism: the CANARY randomized clinical trial","volume":"7","author":"Sadeghipour","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jvsv.2023.06.003_bib28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ahj.2022.05.011","article-title":"Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism: rationale and design of the HI-PEITHO study","volume":"251","author":"Klok","year":"2022","journal-title":"Am Heart J"},{"key":"10.1016\/j.jvsv.2023.06.003_bib29","article-title":"The CXCL10\/CXCR3 Axis and cardiac inflammation: implications for immunotherapy to treat infectious and noninfectious diseases of the heart","volume":"2016","author":"Altara","year":"2016","journal-title":"J\u00a0Immunol Res"},{"key":"10.1016\/j.jvsv.2023.06.003_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141394","article-title":"Left ventricular dysfunction and CXCR3 ligands in hypertension: from animal experiments to a population-based pilot study","volume":"10","author":"Altara","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jvsv.2023.06.003_bib31","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/ejhf.2540","article-title":"Whole blood transcriptomic profiling identifies molecular pathways related to cardiovascular mortality in heart failure","volume":"24","author":"Nath","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jvsv.2023.06.003_bib32","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1161\/CIRCULATIONAHA.113.005544","article-title":"Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism","volume":"129","author":"Kucher","year":"2014","journal-title":"Circulation"}],"container-title":["Journal of Vascular Surgery: Venous and Lymphatic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213333X23002354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213333X23002354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T07:03:48Z","timestamp":1761980628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213333X23002354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2213333X23002354"],"URL":"https:\/\/doi.org\/10.1016\/j.jvsv.2023.06.003","relation":{},"ISSN":["2213-333X"],"issn-type":[{"value":"2213-333X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of chronic thromboembolic pulmonary hypertension in patients with submassive pulmonary embolism treated with catheter-directed thrombolysis versus anticoagulation alone: A secondary analysis of the SUNSET sPE trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery: Venous and Lymphatic Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvsv.2023.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the Society for Vascular Surgery. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}